Delivery Order SPE2DB24D2205-SPE2DB24FDVFB
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The single-award Indefinite Delivery Contract (IDC), valued up to $999,999,999.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen as the prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The $1,097.08 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $1,165.18 and an ultimate completion date of April 23, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, under a Delivery Order contract type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The $3,291.24 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 28, 2024 with a completion date of May 29, 2024. The contract is a Delivery Order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award is a Delivery Order with a Firm Fixed Price of $2,171.78, with an ultimate completion date of April 23, 2024. The contracting agency is the Defense Logistics Agency (DLA), which is a defense agency supporting the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,097.08, has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $5,440.32 firm fixed-price delivery order for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 14, 2024 and was awarded on May 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a potential value of $2,194.16 and a completion date of January 26, 2024. This award does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $1,908.62, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a single-award IDC valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $6,488.12 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDVFBDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $4,404.16 firm fixed-price contract was awarded on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for providing a comprehensive range of pharmaceuticals and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award appears to be a delivery order issued under that larger IDC. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 6/6/24 |